Morningstar
Stock Insight

3M: Stock of the Week

3M stock is a value trap. Its dividend is safe for now, but it may be in danger down the road. 

Ruth Saldanha 4 July, 2023 | 1:00AM
Facebook Twitter LinkedIn
Font-Size

 

 

Explore more Stock of the Week episodes here 

Last week, 3M (MMM) reached a settlement of various lawsuits around the use of “forever chemicals” or PFAS in its products. The chemical company will need to pay out 10.3 billion US dollars at the least. The settlement will be paid over 13-years, and could reach as high as 12.5 billion U.S. dollars, depending on how many public water systems detect PFAS in their testing.

As a result of this settlement, Morningstar analyst Joshua Aguilar has reduced his fair value estimate for the 3M stock to 121 US dollars from 127 US dollars. For now, he is still maintaining his ‘Wide’ economic moat rating and Morningstar Uncertainty Rating of High. He calculates 3M’s total PFAS liabilities at about 20 billion US dollars and thinks its total liabilities will rise to about 24 billion dollars.

Shareholders will be adversely affected no matter what. 3M will have to end its share repurchase program, and it may also have to end its acquisition program and accept a more modest reality. For now, its dividends are safe, but will be in danger down the road.

While Aguilar doesn’t think 3M’s exposure reaches the heights of Big Tobacco – which incurred legal settlements greater than 200 billion U.S. dollars, he does compare it to the BP oil spill settlement. Right now, 3M is a value trap, and investors should search elsewhere for industrials exposure, because 3M’s risk/reward isn’t too attractive at current prices.

For Morningstar, I’m Ruth Saldanha

bulls Bulls Say

  • 3M continues to emphasize innovation and keeps competitors away with generous levels of R&D spending, which typically totals nearly 6% of net sales.
  • The firm continues to benefit from its shared technology platforms, which are applicable to multiple use cases. Technology allows 3M to charge a 10%-30% premium for its products but also brings down its unit costs.
  • 3M is likely to profit from repositioning its portfolio to faster-growing portions of global GDP, which over the long term should allow it to handily outperform the industrial production index.

bears Bears Say

  • While 3M has earned returns that have doubled its cost of capital for over 25 years before the pandemic, gross profits over prior-year R&D spending have started to slow.
  • The firm faces several challenges, including slowing respirator sales that represent an approximately $500 million sales headwind in 2023.
  • Litigation risks will cripple the value of the company and remove any benefit from potential fundamental catalysts.

 

TAGS
Facebook Twitter LinkedIn
Font-Size

About Author

Ruth Saldanha

Ruth Saldanha  is Editorial Manager at Morningstar.ca. Follow her on Twitter @KarishmaRuth.

 
 
 

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy       Disclosures        Accessibility

The Morningstar Star Rating for Stocks is assigned based on an analyst's estimate of a stocks fair value. It is projection/opinion and not a statement of fact. Morningstar assigns star ratings based on an analyst’s estimate of a stock's fair value. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. This process culminates in a single-point star rating that is updated daily. A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn't. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Morningstar Star Rating for Stocks, please visit here

Quantitative Fair Value Estimate represents Morningstar’s estimate of the per share dollar amount that a company’s equity is worth today. The Quantitative Fair Value Estimate is based on a statistical model derived from the Fair Value Estimate Morningstar’s equity analysts assign to companies which includes a financial forecast of the company. The Quantitative Fair Value Estimate is calculated daily. It is a projection/opinion and not a statement of fact. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Quantiative Fair Value Estimate, please visit here

The Morningstar Medalist Rating is the summary expression of Morningstar’s forward-looking analysis of investment strategies as offered via specific vehicles using a rating scale of Gold, Silver, Bronze, Neutral, and Negative. The Medalist Ratings indicate which investments Morningstar believes are likely to outperform a relevant index or peer group average on a risk-adjusted basis over time. Investment products are evaluated on three key pillars (People, Parent, and Process) which, when coupled with a fee assessment, forms the basis for Morningstar’s conviction in those products’ investment merits and determines the Medalist Rating they’re assigned. Pillar ratings take the form of Low, Below Average, Average, Above Average, and High. Pillars may be evaluated via an analyst’s qualitative assessment (either directly to a vehicle the analyst covers or indirectly when the pillar ratings of a covered vehicle are mapped to a related uncovered vehicle) or using algorithmic techniques. Vehicles are sorted by their expected performance into rating groups defined by their Morningstar Category and their active or passive status. When analysts directly cover a vehicle, they assign the three pillar ratings based on their qualitative assessment, subject to the oversight of the Analyst Rating Committee, and monitor and reevaluate them at least every 14 months. When the vehicles are covered either indirectly by analysts or by algorithm, the ratings are assigned monthly. For more detailed information about these ratings, including their methodology, please go to here

The Morningstar Medalist Ratings are not statements of fact, nor are they credit or risk ratings. The Morningstar Medalist Rating (i) should not be used as the sole basis in evaluating an investment product, (ii) involves unknown risks and uncertainties which may cause expectations not to occur or to differ significantly from what was expected, (iii) are not guaranteed to be based on complete or accurate assumptions or models when determined algorithmically, (iv) involve the risk that the return target will not be met due to such things as unforeseen changes in changes in management, technology, economic development, interest rate development, operating and/or material costs, competitive pressure, supervisory law, exchange rate, tax rates, exchange rate changes, and/or changes in political and social conditions, and (v) should not be considered an offer or solicitation to buy or sell the investment product. A change in the fundamental factors underlying the Morningstar Medalist Rating can mean that the rating is subsequently no longer accurate.

For information on the historical Morningstar Medalist Rating for any managed investment Morningstar covers, please contact your local Morningstar office.

For more detailed information about conflicts of interest, including EU MAR disclosures, please see the “Morningstar Medalist Rating Analyst Conflict of Interest & Other Disclosures for EMEA”here

Select Your Site Edition To make sure the site is relevant to you, we need to know if you’re an individual investor or a financial professional.